In human studies, severe malaria has been associated with increased angiopoietin-2, decreased angiopoietin-1, and decreased endothelial nitric oxide levels [76]–[78], and the upregulation of counter-regulatory molecules including HO-1 and erythropoietin [78]–[80]. The gene discussed is EPO; the disease is malaria.